Patricia Fast

6.7k total citations
77 papers, 2.6k citations indexed

About

Patricia Fast is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Patricia Fast has authored 77 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 40 papers in Virology and 30 papers in Epidemiology. Recurrent topics in Patricia Fast's work include HIV Research and Treatment (40 papers), HIV/AIDS Research and Interventions (26 papers) and Vaccine Coverage and Hesitancy (15 papers). Patricia Fast is often cited by papers focused on HIV Research and Treatment (40 papers), HIV/AIDS Research and Interventions (26 papers) and Vaccine Coverage and Hesitancy (15 papers). Patricia Fast collaborates with scholars based in United States, Uganda and United Kingdom. Patricia Fast's co-authors include H S Ko, Ann M. Arvin, Wesley O. McBride, Louis M. Staudt, Mark Wolff, Stanley A. Plotkin, Robert B. Belshe, John F. Modlin, Mark A. Myers and Regina Rabinovich and has published in prestigious journals such as New England Journal of Medicine, Cell and SHILAP Revista de lepidopterología.

In The Last Decade

Patricia Fast

75 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patricia Fast United States 29 1.2k 1.1k 843 716 670 77 2.6k
Raúl Gómez Román United States 17 425 0.4× 1.1k 1.1× 719 0.9× 714 1.0× 463 0.7× 24 2.4k
Denise Naniche Spain 32 1.8k 1.5× 1.5k 1.4× 595 0.7× 930 1.3× 354 0.5× 104 3.8k
Mark Pandori United States 31 964 0.8× 1.8k 1.6× 1.0k 1.2× 376 0.5× 461 0.7× 83 3.3k
Michael C. Keefer United States 31 730 0.6× 691 0.6× 1.3k 1.5× 918 1.3× 647 1.0× 71 2.2k
Ann Chahroudi United States 29 999 0.8× 1.0k 0.9× 1.5k 1.8× 1.6k 2.2× 424 0.6× 101 3.3k
Vivek Naranbhai United States 28 682 0.6× 2.4k 2.2× 390 0.5× 1.1k 1.6× 918 1.4× 78 4.0k
Fulvia Veronese United States 23 1.0k 0.9× 1.7k 1.6× 1.7k 2.0× 631 0.9× 767 1.1× 44 3.3k
Sorachai Nitayaphan Thailand 26 437 0.4× 951 0.9× 1.0k 1.2× 503 0.7× 291 0.4× 82 1.8k
Saladin Osmanov Switzerland 27 769 0.6× 2.2k 2.1× 2.7k 3.3× 482 0.7× 538 0.8× 56 3.2k
Assan Jaye Gambia 33 891 0.7× 1.3k 1.2× 1.2k 1.4× 1.0k 1.4× 312 0.5× 81 2.8k

Countries citing papers authored by Patricia Fast

Since Specialization
Citations

This map shows the geographic impact of Patricia Fast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Fast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Fast more than expected).

Fields of papers citing papers by Patricia Fast

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Fast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Fast. The network helps show where Patricia Fast may publish in the future.

Co-authorship network of co-authors of Patricia Fast

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Fast. A scholar is included among the top collaborators of Patricia Fast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Fast. Patricia Fast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reed, Nicholas S., Carmen C. Brewer, Patricia Fast, et al.. (2024). Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccines. Vaccine. 43(Pt 1). 126525–126525. 1 indexed citations
2.
Alba, Ana Carolina, Colin A. Chapman, Coleen K. Cunningham, et al.. (2022). Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for all infants born in high-burden settings. SPIRE - Sciences Po Institutional REpository. 1 indexed citations
3.
Nakamanya, Sarah, Elialilia S. Okello, Zachary Kwena, et al.. (2022). Social networks, mobility, and HIV risk among women in the fishing communities of Lake Victoria. BMC Women s Health. 22(1). 555–555. 7 indexed citations
4.
Abaasa, Andrew, Jim Todd, Yunia Mayanja, et al.. (2019). Use of reliable contraceptives and its correlates among women participating in Simulated HIV vaccine efficacy trials in key-populations in Uganda. Scientific Reports. 9(1). 15418–15418. 2 indexed citations
5.
Stephenson, Kathryn E., Michael C. Keefer, Catherine A. Bunce, et al.. (2018). First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1. PLoS ONE. 13(11). e0205139–e0205139. 28 indexed citations
6.
7.
Mahan, Alison E., Madeleine F. Jennewein, Todd J. Suscovich, et al.. (2016). Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination. PLoS Pathogens. 12(3). e1005456–e1005456. 107 indexed citations
8.
Hayes, Peter, Jill Gilmour, Dilbinder K. Gill, et al.. (2013). Safety and Immunogenicity of DNA Prime and Modified Vaccinia Ankara Virus-HIV Subtype C Vaccine Boost in Healthy Adults. Clinical and Vaccine Immunology. 20(3). 397–408. 22 indexed citations
9.
10.
Amornkul, Pauli N., Etienne Karita, Anatoli Kamali, et al.. (2013). Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa. AIDS. 27(17). 2775–2786. 73 indexed citations
11.
Mutua, Gaudensia, Eduard J. Sanders, Peter Mugo, et al.. (2012). Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers. PLoS ONE. 7(4). e33103–e33103. 133 indexed citations
12.
Burgers, Wendy A., Heather B. Jaspan, Linda‐Gail Bekker, et al.. (2011). Intra- and Inter-clade Cross-reactivity by HIV-1 Gag Specific T-Cells Reveals Exclusive and Commonly Targeted Regions: Implications for Current Vaccine Trials. PLoS ONE. 6(10). e26096–e26096. 11 indexed citations
13.
Omosa-Manyonyi, Gloria, Walter Jaoko, Omu Anzala, et al.. (2011). Reasons for Ineligibility in Phase 1 and 2A HIV Vaccine Clinical Trials at Kenya Aids Vaccine Initiative (KAVI), Kenya. PLoS ONE. 6(1). e14580–e14580. 14 indexed citations
14.
Excler, Jean‐Louis, Wasima Rida, Frances Priddy, et al.. (2010). AIDS Vaccines and Preexposure Prophylaxis: Is Synergy Possible?. AIDS Research and Human Retroviruses. 27(6). 669–680. 26 indexed citations
15.
Fast, Patricia & Pontiano Kaleebu. (2010). HIV vaccines: current status worldwide and in Africa. AIDS. 24(Suppl 4). S50–S60. 11 indexed citations
16.
Sanders, Eduard J., Simon Graham, Haile Selassie Okuku, et al.. (2007). Risk factors for HIV-1 infection and high HIV-1 incidence of men who have sex with men, in and around Mombasa, Kenya. Tropical Medicine & International Health. 12. 88–88. 2 indexed citations
17.
King, James C., Patricia Fast, Kenneth M. Zangwill, et al.. (2001). Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children. The Pediatric Infectious Disease Journal. 20(12). 1124–1131. 67 indexed citations
18.
Evans, Thomas G., M. Juliana McElrath, Thomas J. Matthews, et al.. (2001). QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans. Vaccine. 19(15-16). 2080–2091. 106 indexed citations
19.
Golding, Hana, M. Patricia D’Souza, James A. Bradac, Bonnie J. Mathieson, & Patricia Fast. (1994). Neutralization of HIV-1. AIDS Research and Human Retroviruses. 10(6). 633–643. 51 indexed citations
20.
Mofenson, Lynne, Peter F. Wright, & Patricia Fast. (1992). Summary of the Working Group on Perinatal Intervention. AIDS Research and Human Retroviruses. 8(8). 1435–1438. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raúl Gómez Román Breakdown of academic impact, for papers by Denise Naniche Breakdown of academic impact, for papers by Mark Pandori Breakdown of academic impact, for papers by Michael C. Keefer Breakdown of academic impact, for papers by Ann Chahroudi Breakdown of academic impact, for papers by Vivek Naranbhai Breakdown of academic impact, for papers by Fulvia Veronese Breakdown of academic impact, for papers by Sorachai Nitayaphan Breakdown of academic impact, for papers by Saladin Osmanov Breakdown of academic impact, for papers by Assan Jaye
Rankless by CCL
2026